Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ciprofloxacin Derivative‐Loaded Nanoparticles Synergize with Paclitaxel Against Type II Human Endometrial Cancer
Youssef W. Naguib, Suhaila O. Alhaj‐Suliman, Emad I. Wafa, et al.
Small (2023)
Open Access | Times Cited: 11

Showing 11 citing articles:

Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics
Yang Yang, Lixia Liu, Yu Tian, et al.
Cancer Letters (2024) Vol. 587, pp. 216659-216659
Open Access | Times Cited: 66
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 6
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
Hesham M. Hassan, Roket Hassan, Ranya Mohammed Elmagzoub, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 72-72
Open Access
Investigating the attenuating effects of metformin-loaded selenium nanoparticles coupled with Myrtus communis L. flower extract on CaOx deposition in male Sprague Dawley rat kidneys via regulating MAPK signaling pathway
Jian Kang, YanQing Tong
Regenerative Therapy (2024) Vol. 26, pp. 14-26
Open Access | Times Cited: 1
Drug repurposing of fluoroquinolones as anticancer agents in 2023
Asmaa E. Kassab, Rania M. Gomaa, Ehab M. Gedawy
RSC Advances (2024) Vol. 14, Iss. 50, pp. 37114-37130
Open Access | Times Cited: 1
An insight into the therapeutic impact of quinoxaline derivatives: Recent advances in biological activities (2020–2024)
Aly M. Waseem, Ranya Mohammed Elmagzoub, Mervat Mohammed Mazhar Abdelgadir, et al.
Results in Chemistry (2024), pp. 101989-101989
Open Access | Times Cited: 1
Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo pharmacokinetics in mice
David S. Nakhla, Aml I. Mekkawy, Youssef W. Naguib, et al.
International Journal of Pharmaceutics (2023) Vol. 650, pp. 123693-123693
Open Access | Times Cited: 2
Nanomedicine for Women's Health
Tamara Minko, Oleh Taratula
Small (2024)
Closed Access
Oral nano-formulations for endocrine therapy of endometrioid adenocarcinomas
Minghua Cui, Yuehui Liu, Yangyang Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117328-117328
Open Access
Multidisciplinary examples of applications: Papers using the MAL-PD/BD/CI/BI theory/method
Ting-Chao Chou
Elsevier eBooks (2024), pp. 181-218
Closed Access
Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA‐sequencing and methylation modification data in endometrial cancer
Huanzhen Zhou, Yingzhi Zhang, Jing Jin, et al.
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Open Access
Page 1

Scroll to top